12:57 EST Novartis in advanced talks to acquire Cytokinetics, WSJ reports
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CYTK:
- Liquidia added to Conviction Buy, named 2024 Top Pick at Needham
- Cytokinetics downgraded to Equal Weight from Overweight at Morgan Stanley
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- The biotech stocks to own in 2024, according to Piper Sandler
